Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Pathologic Complete Response × Rituximab × Clear all

Sponsor

Conditions

Lymphoma 150 Leukemia, Lymphocytic, Chronic, B-Cell 138 Lymphoma, Non-Hodgkin 135 Lymphoma, Follicular 117 Lymphoma, Large B-Cell, Diffuse 114 Lymphoma, Mantle-Cell 81 Leukemia 63 Lymphoma, B-Cell, Marginal Zone 59 Waldenstrom Macroglobulinemia 44 Burkitt Lymphoma 37 Lymphoma, B-Cell 34 Precursor Cell Lymphoblastic Leukemia-Lymphoma 33 Hodgkin Disease 32 Recurrence 22 Lymphoma, Large-Cell, Immunoblastic 22 Neoplasms 15 Myelodysplastic Syndromes 15 Lymphoma, Large-Cell, Anaplastic 13 Multiple Myeloma 12 Leukemia, Myeloid, Acute 12 Hematologic Neoplasms 9 Lymphoma, T-Cell, Cutaneous 7 Lymphoma, Extranodal NK-T-Cell 7 Leukemia, Prolymphocytic 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Leukemia, Hairy Cell 7 Intraocular Lymphoma 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Myeloproliferative Disorders 6 Leukemia, Myelomonocytic, Chronic 6

Interventions

temsirolimus 1 sargramostim 1 ruxolitinib 1 rucaparib 1 pazopanib 1 olaparib 1 eltrombopag 1 cc-486 1 Surveys and Questionnaires 1 Nivolumab 1 Monatide (IMS 3015) 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Doxorubicin 1 Docetaxel 1 Diphenhydramine 1 Cytarabine 1 Cyclophosphamide 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡